EUVIMEDEUVIMED entdecken
Crossref

Proton beam therapy with or without transarterial chemoembolization for hepatocellular carcinoma: a propensity score matching analysis

Jen-Yu Cheng iD, Hee Chul Park, Jeong Il Yu iD, Nalee Kim, Jeong Ha Lee, Sung Koo Cho, Dongho Hyun, Yong-Han Paik

British Journal of Radiology · 01.06.2026 · 99 (1182) · 1221-1231

DOI: 10.1093/bjr/tqag074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Radiology, online erschienen am 07.04.2026. Verfasst von Jen-Yu Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology & Proton and Radiation Therapy Center, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medi…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic, Proton Therapy. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Basic Science Research Program, National Research Foundation of Korea, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study compared the efficacies of proton beam therapy (PBT) alone and PBT after transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC).

Methods

We retrospectively studied 917 patients with HCC treated with PBT alone (PBT group, n = 354) or PBT following TACE (TACE-PBT group, n = 563) between 2016 and 2024.

Results

Before propensity score matching (PSM), there were no significant differences in local control (LC) or overall survival (OS). After PSM, there was no difference in OS between the 2 groups (P = .124), while LC showed a trend toward favoring TACE-PBT group (2-year LC: 97.4% vs. 94.8%, P = .068). In the subgroup of patients with mALBI grade 1 and absence of portal vein tumor thrombus, both LC and OS were significantly improved (P = .017 and P = .002, respectively). Moreover, there were no significant differences in mALBI grade distribution at 1, 3, and 6 months post-treatment (P = .231, P = .158, and P = .683, respectively).

Conclusions

While adding TACE before PBT marginally improved LC, it did not confer any benefit in the OS. Given the excellent LC achieved with PBT alone, the modest absolute benefit of adding TACE should be carefully weighed against individual patient factors. Advances in knowledge This first large-scale study comparing PBT alone and TACE-PBT in HCC patients, demonstrating that PBT alone achieves excellent LC, with limited additional benefit from TACE except in selected subgroups. These findings help refine patient selection for combined therapy to maximize clinical benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsChemoembolization, TherapeuticProton TherapyHumansRetrospective StudiesPropensity ScoreFemaleMaleMiddle AgedCombined Modality TherapyTreatment OutcomeAged

Stichwörter der Autor:innen

local controlprotonradiation therapytransarterial chemo-embolization

Autor:innen und Institutionen

  • Department of Radiation Oncology & Proton and Radiation Therapy Center, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
  • Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, South Korea.
  • Department of Radiology, Ewha Womans University Medical Center, Seoul 07804, South Korea.
  • Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, South Korea.

ORCID-Profile: Jen-Yu Cheng, Jeong Il Yu

Förderung

  • Basic Science Research Program
  • National Research Foundation of Korea
  • Ministry of Education

Zitieren

APA

Cheng, J. Y., Park, H. C., Yu, J. I., Kim, N., Lee, J. H., Cho, S. K., Hyun, D., & Paik, Y. H. (2026). Proton beam therapy with or without transarterial chemoembolization for hepatocellular carcinoma: a propensity score matching analysis. British Journal of Radiology, 99(1182), 1221-1231. https://doi.org/10.1093/bjr/tqag074

Vancouver

Cheng JY, Park HC, Yu JI, Kim N, Lee JH, Cho SK, et al. Proton beam therapy with or without transarterial chemoembolization for hepatocellular carcinoma: a propensity score matching analysis. British Journal of Radiology. 2026;99(1182):1221-1231. doi:10.1093/bjr/tqag074

BibTeX
@article{Cheng2026,
  author = {Cheng, Jen-Yu and Park, Hee Chul and Yu, Jeong Il and Kim, Nalee and Lee, Jeong Ha and Cho, Sung Koo and Hyun, Dongho and Paik, Yong-Han},
  title = {Proton beam therapy with or without transarterial chemoembolization for hepatocellular carcinoma: a propensity score matching analysis},
  journal = {British Journal of Radiology},
  year = {2026},
  volume = {99},
  number = {1182},
  pages = {1221--1231},
  doi = {10.1093/bjr/tqag074}
}
Kostenlos starten →